Pharma companies struggle as input costs rise despite 0.6% price hike

Facing a modest 0.6% hike in medicine prices this year, pharmaceutical companies are grappling with the rising costs of raw materials fueled by global unrest. Starting April 1, essential medications such as pain relievers and antibiotics will adjust in price, prompting the industry to appeal to governments for financial relief to manage these escalating expenses.